Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA), a chronic autoimmune disorder, imposes a substantial global health burden through elevated disability rates, systemic complications, and socioeconomic consequences. Chronic synovitis and progressive joint destruction characterize this disease, driven by dysregulated innate...
Saved in:
| Main Authors: | Kexin Wang, Haoge Luo, Liping Liu, Hang Gao, Yanyan Song, Dong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1577628/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?
by: E. L. Nasonov, et al.
Published: (2023-04-01) -
Study the Serum IL-6 Level between Rheumatoid Arthritis Patients and Control
by: Semaa Abdulrahman Shaban
Published: (2023-02-01) -
Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study
by: V. I. Mazurov, et al.
Published: (2021-05-01) -
Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
by: V. I. Mazurov, et al.
Published: (2023-03-01) -
Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)
by: V. I. Mazurov, et al.
Published: (2021-08-01)